Laboratory Medicine Program

Polymorphous Low Grade Adenocarcinoma (PLGA) Salivary gland

Clinical Decription:
Polymorphous low-grade adenocarcinoma (PLGA) is the second most frequent type of malignant tumor of the minor salivary glands and carries an excellent prognosis. Unfortunately, it demonstrates cytological overlap with two other salivary gland tumors frequently encountered in teh same location. Mutations in the PRKD1 gene are demonstrated to be specific for PLGA and is present in the majority of cases. Tumor tissue testing is performed on PLGA tumors to facilitate diagnosis and therapeutic management.

Method: PCR - Sanger Sequencing

Component Tests Used: n/a

Reference Ranges Used:
Reference ranges for this test are not available online. However, they are included in all test results. For more information, please call us.

Specimen Type: Paraffin-embedded material (FFPE)/Cytology fluids
Volume: n/a

Shipping: room temperature or 4C

Special Instructions: This test will be billed to a hospital, referring laboratory, referring physician or medical group. See requisitions for the full list of available testing and special instructions.

Testing Schedule(s): Please call

Turnaround Time: None

For more information, call 416.340.5227 or 1.866.865.5227